Tag: Elevar Therapeutics

October 25, 2019 Off

Neopharma, Elevar Therapeutics form JV to sell anticancer drug Rivoceranib

Abu Dhabi-based pharmaceutical manufacturer Neopharma and US-based Elevar Therapeutics formed a 50-50 joint venture in UAE, to organize selling Rivoceranib, a targeted anticancer drug and conduct clinical trials for other pipeline candidates.

September 30, 2019 Off

Elevar Therapeutic’s rivoceranib trial has potential to treat late-stage gastric cancer patients, study says

By Dino Mustafić

Elevar Therapeutics presented a study at ESMO, showing the potential of rivoceranib to treat patients with late-stage gastric cancer, which was is the first multinational phase 3 study after rivoceranib’s approval in China, said Dr. Steven Norton, Elevar Therapeutics’ Vice President of Clinical Development.